The rapid global outbreak of a novel coronavirus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), caused the coronavirus disease 2019 (COVID-19) pandemic, which has claimed more ...

In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper understanding of the development process, enabling you to streamline the ...

The lateral flow assay market is poised for growth via increasing home-based self-testing kits, integration with smartphones for telehealth, and expansions in food safety and environmental monitoring.

Bond Digital Health Ltd. landed £1 million (US$1.3 million) from investors to expand development of its Transform data management system for lateral flow diagnostic tests. The technology connects to ...

The COVID-19 pandemic has highlighted the need for rapid and accurate nucleic acid detection at the point of care. To meet this need, scientists from the Suzhou Institute of Biomedical Engineering and ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

DUBLIN--(BUSINESS WIRE)--The "Lateral Flow Immunoassay Based Rapid Test Market by Application Type Technique type and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

With the revolution of lateral flow assay use in Point-of-Care and Over-the-Counter testing resulting from Covid-19, saliva has become an attractive sample matrix. To continue to grow lateral flow ...

The COVID-19 pandemic has highlighted the need for rapid and accurate nucleic acid detection at the point of care. To meet this need, scientists from the Suzhou Institute of Biomedical Engineering and ...

The availability of rapid antigen tests for the COVID-19 pandemic has been far short of ideal in recent weeks despite a recent order by the Biden administration for half a billion tests. The question ...